Elsevier

Annals of Oncology

Volume 28, Issue 8, August 2017, Pages 2009-2012
Annals of Oncology

Industry corner: perspectives and controversies
Blinatumomab (Blincyto): lessons learned from the bispecific t-cell engager (BiTE) in acute lymphocytic leukemia (ALL)

https://doi.org/10.1093/annonc/mdx150Get rights and content
Under an Elsevier user license
open archive

Cited by (0)